Work Programme 2023 for the EU Initiative on Health Security, which works to set up a regional workforce responsible for the prevention and control of communicable diseases.
Mpox (previously known as monkeypox) is not a newly discovered disease. The 2022 outbreak however showed that it may spread through a completely different route.
In 2021, 14 560 cases of hepatitis C were reported in 29 EU/EEA Member States. Excluding countries that only reported acute cases the number of cases (14 550 cases) corresponds to a crude rate of 4.1 cases per 100 000 population.
The training aimed to engage in a discussion on how to refine the skills of Tunisia's health workforce to rapidly detect and assess public health threats, to propose options for response to such threats, and to communicate on related situations and decisions.
Chikungunya is not endemic in the EU/EEA and the majority of the cases are travellers infected outside of the EU/EEA. When the environmental conditions are favourable, in areas where Ae. albopictus is established, viraemic travel-related cases may generate a local transmission of the virus as demonstrated by the sporadic events of chikungunya virus transmission since 2007.
Influenza activity had been decreasing across the Region since week 51/2022, with a slight increase in positivity in primary care sentinel observed in week 5/2023 related to type B virus circulation. Influenza intensity remains at moderate or high levels in many countries.
This protocol presents a common methodology to estimate vaccine effectiveness (VE) for COVID-19, using established health data registries in participating EU/EEA Member States.